Moderna
MRNA
#1830
Rank
HK$84.22 B
Marketcap
HK$215.56
Share price
8.67%
Change (1 day)
-35.49%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Moderna (MRNA) - Total assets

Total assets on the balance sheet as of September 2025 : HK$94.43 Billion

According to Moderna 's latest financial reports the company's total assets are HK$94.43 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Moderna - Total assets on balance sheet (from 2017 to 2025)

Total assets by year

Year Total assets Change
2024-12-31HK$109.79 B-23.71%
2023-12-31HK$143.90 B-28.77%
2022-12-31HK$202.03 B5.03%
2021-12-31HK$192.35 B238.2%
2020-12-31HK$56.87 B359.49%
2019-12-31HK$12.37 B-19.44%
2018-12-31HK$15.36 B81.34%
2017-12-31HK$8.47 B-22.9%
2016-12-31HK$10.98 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Regulus Therapeutics
RGLS
HK$0.58 B-99.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$1.008 T 967.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
HK$57.8 M-99.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
HK$37.75 B-60.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$834.89 B 784.13%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Arrowhead Pharmaceuticals
ARWR
HK$10.74 B-88.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
HK$1.500 T 1,488.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA